Effect of the Particle Size of Galactosylated Lipoplex on Hepatocyte-Selective Gene Transfection after Intraportal Administration

Abstract

The purpose of this study was to examine the effect of the size of galactosylated cationic liposome (Gal-liposome)/plasmid DNA complex (Gal-lipoplex) on hepatocyte-selective gene transfection after intraportal administration. pCMV-Luc was selected as a model plasmid DNA. After intraportal administration of Gal-lipoplex to mice, the hepatic and intrahepatic gene expression was evaluated. To evaluate the effect of size, three different sizes of Gal-liposome were prepared. The mean particle sizes of Gal-lipoplex were about 141, 179, and 235 nm, respectively. The hepatic transfection efficacy was significantly enhanced by increasing the size of Gal-lipoplex. However, the gene expression in liver parenchymal cells (PC) of Gal-lipoplex of about 141 nm in size was significantly higher than that in liver non-parenchymal cells (NPC). In contrast, gene expression in PC of Gal-lipoplex of about 235 nm in size was significantly lower than that in NPC. These results highlight the importance of the Gal-lipoplex size for hepatocyte-selective gene transfer in vivo. The information in this study will be valuable for the future use, design, and development of Gal-lipoplex for in vivo applications.

Development and optimization of nanosomal formulations for siRNA delivery to the liver

“…Several articles published recently have suggested that the particle size of a delivery system should not exceed 150 nm for successful targeting to the liver hepatic cells [24,25]. This is because the endothelial fenestrae have an approximate diameter of 150–175 nm [33].…”

“…Successful siRNA therapy for HCV in the liver warrants that these siRNA nanosome particles be small enough to prevent clogging of capillaries, and be able to pass the endothelial cell barrier to reach the hepatocytes [24,25]. The nanosomes should also maintain siRNA’s functional integrity during formulation processing, as well as in the tissue environment during their passage to the target site.…”

Development of Dioctadecyldimethylammonium Bromide/Monoolein Liposomes for Gene Delivery

“…More recently, cationic lipids with amino acid headgroup (serine, alanine) [119,120] and sugar-based cationic lipids (D-galactose) have appeared as promising families of cationic surfactants [121,122]. Small molecular weight peptides (glutamate, cysteine) augment the hydrophilicity of the lipoplex surface, as with small surface sugars (galactose, mannose) that additionally allow targetability of the lipoplexes.…”

Advancing Nonviral Gene Delivery: Lipid- and Surfactant-Based Nanoparticle Design Strategies

“…Using cell cultures, numerous studies have found efficient transfection for complexes with sizes falling within the medium-to-large range, but not greater than 400 nm [161,167]. This particle size range is better suited for cell attachment, spontaneous uptake and inducing endosomal disruption to release DNA in actively endocytosing cells.…”